17-4487886-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182538.5(SPNS3):c.1531G>A(p.Glu511Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182538.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPNS3 | NM_182538.5 | c.1531G>A | p.Glu511Lys | missense_variant | 12/12 | ENST00000355530.7 | NP_872344.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPNS3 | ENST00000355530.7 | c.1531G>A | p.Glu511Lys | missense_variant | 12/12 | 2 | NM_182538.5 | ENSP00000347721.2 | ||
SPNS3 | ENST00000575194.5 | n.*785G>A | non_coding_transcript_exon_variant | 11/11 | 1 | ENSP00000460781.1 | ||||
SPNS3 | ENST00000575194.5 | n.*785G>A | 3_prime_UTR_variant | 11/11 | 1 | ENSP00000460781.1 | ||||
SPNS3 | ENST00000575796.1 | n.*24G>A | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152272Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 251022Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135718
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461528Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 727076
GnomAD4 genome AF: 0.000131 AC: 20AN: 152272Hom.: 0 Cov.: 34 AF XY: 0.000121 AC XY: 9AN XY: 74396
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 11, 2022 | The c.1531G>A (p.E511K) alteration is located in exon 12 (coding exon 12) of the SPNS3 gene. This alteration results from a G to A substitution at nucleotide position 1531, causing the glutamic acid (E) at amino acid position 511 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at